Phase 3 trial of ibrutinib plus rituximab in Waldenström's macroglobulinemia - Dimopoulos, M A; Tedeschi, A; Trotman, J; iNNOVATE Study Group and the European Consortium for Waldenström's Macroglobulinemia (N Engl J Med, 2018)